Michael Gleeson Insider Trading $GNMK GenMark Diagnostics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael Gleeson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael Gleeson. Michael Gleeson is SVP, Corp. Accounts in GenMark Diagnostics, Inc. ($GNMK) and SVP, North American Com. Ops. in GenMark Diagnostics, Inc. ($GNMK) and SVP, Sales in GenMark Diagnostics, Inc. ($GNMK).
Michael Gleeson in GenMark Diagnostics, Inc.
Trading Symbol: GNMKIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Michael Gleeson: SVP, Corp. Accounts, SVP, North American Com. Ops., SVP, Sales
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 22 2021
$GNMK Market Capitalization: $508.12M
$GNMK Previous Close: $11.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Michael Gleeson in GenMark Diagnostics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 22 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Option Exercise | D | 0.00 | 12,500 | 0 | 0 | |
Apr 22 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Option Exercise | D | 0.00 | 38,334 | 0 | 0 | |
Apr 22 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Option Exercise | D | 0.00 | 16,668 | 0 | 0 | |
Apr 22 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Option Exercise | D | 13.17 | 55,674 | 733,227 | 0 | |
Apr 22 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Option Exercise | D | 12.30 | 62,046 | 763,166 | 0 | |
Apr 22 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Option Exercise | D | 10.89 | 20,213 | 220,120 | 0 | |
Apr 22 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | U | 24.05 | 30,069 | 723,159 | 0 | 30.1 K to 0 (-100.00 %) |
Apr 22 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | U | 24.05 | 421,383 | 10,134,261 | 0 | 421.4 K to 0 (-100.00 %) |
Apr 16 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Option Exercise | M | 10.89 | 12,787 | 139,250 | 12,001 | |
Apr 16 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Option Exercise | M | 13.17 | 4,926 | 64,875 | 989 | |
Apr 16 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Option Exercise | M | 12.30 | 9,954 | 122,434 | 5,118 | |
Apr 16 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Buy | M | 10.89 | 12,787 | 139,250 | 420,410 | 407.6 K to 420.4 K (+3.14 %) |
Apr 16 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Buy | M | 13.17 | 4,926 | 64,875 | 407,623 | 402.7 K to 407.6 K (+1.22 %) |
Apr 16 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Buy | M | 12.30 | 9,954 | 122,434 | 402,697 | 392.7 K to 402.7 K (+2.53 %) |
Mar 01 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 17.01 | 17,750 | 301,928 | 392,743 | 410.5 K to 392.7 K (-4.32 %) |
Feb 25 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 19.12 | 2,463 | 47,093 | 410,493 | 413 K to 410.5 K (-0.60 %) |
Feb 25 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 19.35 | 1,432 | 27,709 | 412,956 | 414.4 K to 413 K (-0.35 %) |
Feb 22 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Option Exercise | A | 0.00 | 6,250 | 0 | 6,250 | |
Feb 22 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 21.80 | 2,340 | 51,012 | 414,388 | 416.7 K to 414.4 K (-0.56 %) |
Feb 22 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Grant | A | 0.00 | 18,750 | 0 | 416,728 | 398 K to 416.7 K (+4.71 %) |
Jan 25 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Option Exercise | M | 0.00 | 19,166 | 0 | 19,167 | |
Jan 25 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Option Exercise | M | 0.00 | 27,115 | 0 | 8,333 | |
Jan 25 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Option Exercise | M | 0.00 | 37,555 | 0 | 0 | |
Jan 25 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 14.22 | 33,027 | 469,644 | 397,978 | 431 K to 398 K (-7.66 %) |
Jan 25 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Buy | M | 0.00 | 19,166 | 0 | 431,005 | 411.8 K to 431 K (+4.65 %) |
Jan 25 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Buy | M | 0.00 | 27,115 | 0 | 411,839 | 384.7 K to 411.8 K (+7.05 %) |
Jan 25 2021 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Buy | M | 0.00 | 37,555 | 0 | 384,724 | 347.2 K to 384.7 K (+10.82 %) |
Nov 20 2020 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 13.85 | 1,637 | 22,672 | 350,403 | 352 K to 350.4 K (-0.47 %) |
Aug 26 2020 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 14.14 | 2,904 | 41,063 | 352,040 | 354.9 K to 352 K (-0.82 %) |
Aug 24 2020 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 15.41 | 1,691 | 26,058 | 354,944 | 356.6 K to 354.9 K (-0.47 %) |
Aug 14 2020 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | J | 0.00 | 78,725 | 0 | 354,402 | 433.1 K to 354.4 K (-18.18 %) |
Jun 01 2020 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 9.52 | 2,815 | 26,799 | 433,127 | 435.9 K to 433.1 K (-0.65 %) |
May 20 2020 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 10.46 | 1,648 | 17,238 | 435,942 | 437.6 K to 435.9 K (-0.38 %) |
May 08 2020 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Option Exercise | M | 6.49 | 56,816 | 368,736 | 0 | |
May 08 2020 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Payment of Exercise | F | 12.84 | 28,718 | 368,739 | 437,590 | 466.3 K to 437.6 K (-6.16 %) |
May 08 2020 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Buy | M | 6.49 | 56,816 | 368,736 | 466,308 | 409.5 K to 466.3 K (+13.87 %) |
Feb 28 2020 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 3.51 | 1,996 | 7,006 | 409,492 | 411.5 K to 409.5 K (-0.49 %) |
Feb 27 2020 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Option Exercise | A | 0.00 | 28,750 | 0 | 28,750 | |
Feb 27 2020 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 3.81 | 1,053 | 4,012 | 411,488 | 412.5 K to 411.5 K (-0.26 %) |
Feb 27 2020 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Grant | A | 0.00 | 43,125 | 0 | 412,541 | 369.4 K to 412.5 K (+11.67 %) |
Feb 27 2020 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Grant | A | 0.00 | 43,125 | 0 | 369,416 | 326.3 K to 369.4 K (+13.22 %) |
Feb 21 2020 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 3.80 | 9,701 | 36,864 | 326,291 | 336 K to 326.3 K (-2.89 %) |
Jan 23 2020 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Option Exercise | M | 0.00 | 6,216 | 0 | 18,784 | |
Jan 23 2020 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Option Exercise | M | 0.00 | 5,347 | 0 | 11,305 | |
Jan 23 2020 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 4.93 | 4,988 | 24,591 | 335,992 | 341 K to 336 K (-1.46 %) |
Jan 23 2020 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Buy | M | 0.00 | 11,563 | 0 | 340,980 | 329.4 K to 341 K (+3.51 %) |
Nov 27 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 5.60 | 20,099 | 112,554 | 329,417 | 349.5 K to 329.4 K (-5.75 %) |
Nov 26 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 5.43 | 2,728 | 14,813 | 349,516 | 352.2 K to 349.5 K (-0.77 %) |
Nov 21 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 5.55 | 1,746 | 9,690 | 352,244 | 354 K to 352.2 K (-0.49 %) |
Nov 21 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 5.55 | 1,746 | 9,690 | 352,244 | 354 K to 352.2 K (-0.49 %) |
Aug 30 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 6.03 | 2,766 | 16,679 | 353,990 | 356.8 K to 354 K (-0.78 %) |
Aug 30 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 6.03 | 2,766 | 16,679 | 353,990 | 356.8 K to 354 K (-0.78 %) |
Aug 21 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 6.25 | 1,821 | 11,381 | 356,756 | 358.6 K to 356.8 K (-0.51 %) |
May 31 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 6.60 | 1,729 | 11,411 | 358,577 | 360.3 K to 358.6 K (-0.48 %) |
May 28 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 6.62 | 1,029 | 6,812 | 360,306 | 361.3 K to 360.3 K (-0.28 %) |
May 22 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 6.83 | 1,766 | 12,062 | 361,335 | 363.1 K to 361.3 K (-0.49 %) |
May 07 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 8.00 | 10,000 | 80,000 | 363,101 | 373.1 K to 363.1 K (-2.68 %) |
Apr 16 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 7.51 | 10,000 | 75,100 | 373,101 | 383.1 K to 373.1 K (-2.61 %) |
Mar 01 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 7.84 | 18,464 | 144,758 | 383,101 | 401.6 K to 383.1 K (-4.60 %) |
Mar 01 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 7.96 | 26,704 | 212,564 | 401,565 | 428.3 K to 401.6 K (-6.24 %) |
Feb 27 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 6.79 | 12,097 | 82,139 | 428,269 | 440.4 K to 428.3 K (-2.75 %) |
Feb 21 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Feb 21 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 6.16 | 2,121 | 13,065 | 440,366 | 442.5 K to 440.4 K (-0.48 %) |
Feb 21 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Grant | A | 0.00 | 75,000 | 0 | 442,487 | 367.5 K to 442.5 K (+20.41 %) |
Jan 25 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 5.90 | 3,974 | 23,447 | 367,487 | 371.5 K to 367.5 K (-1.07 %) |
Jan 22 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Option Exercise | M | 0.00 | 9,600 | 0 | 16,650 | |
Jan 22 2019 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Buy | M | 0.00 | 9,600 | 0 | 371,461 | 361.9 K to 371.5 K (+2.65 %) |
Nov 29 2018 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 5.08 | 970 | 4,928 | 361,861 | 362.8 K to 361.9 K (-0.27 %) |
Nov 26 2018 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 4.84 | 1,814 | 8,780 | 362,831 | 364.6 K to 362.8 K (-0.50 %) |
Nov 06 2018 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, Corp. Accounts | Sell | S | 4.85 | 382 | 1,853 | 364,645 | 365 K to 364.6 K (-0.10 %) |
Aug 27 2018 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 7.16 | 1,022 | 7,318 | 365,027 | 366 K to 365 K (-0.28 %) |
Aug 22 2018 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 7.39 | 1,774 | 13,110 | 366,049 | 367.8 K to 366 K (-0.48 %) |
Aug 06 2018 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 7.20 | 351 | 2,527 | 367,823 | 368.2 K to 367.8 K (-0.10 %) |
May 24 2018 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 6.88 | 984 | 6,770 | 366,674 | 367.7 K to 366.7 K (-0.27 %) |
May 22 2018 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 6.91 | 1,764 | 12,189 | 367,658 | 369.4 K to 367.7 K (-0.48 %) |
May 04 2018 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 6.18 | 359 | 2,219 | 369,422 | 369.8 K to 369.4 K (-0.10 %) |
Feb 27 2018 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Option Exercise | A | 0.00 | 26,250 | 0 | 26,250 | |
Feb 27 2018 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 4.17 | 4,715 | 19,662 | 370,173 | 374.9 K to 370.2 K (-1.26 %) |
Feb 27 2018 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Grant | A | 0.00 | 88,250 | 0 | 374,888 | 286.6 K to 374.9 K (+30.79 %) |
Feb 21 2018 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 4.37 | 2,134 | 9,326 | 286,638 | 288.8 K to 286.6 K (-0.74 %) |
Feb 06 2018 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 5.13 | 437 | 2,242 | 288,772 | 289.2 K to 288.8 K (-0.15 %) |
Dec 06 2017 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 4.70 | 499 | 2,345 | 287,140 | 287.6 K to 287.1 K (-0.17 %) |
Nov 21 2017 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 4.74 | 2,666 | 12,637 | 287,639 | 290.3 K to 287.6 K (-0.92 %) |
Nov 03 2017 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 7.24 | 554 | 4,011 | 290,305 | 290.9 K to 290.3 K (-0.19 %) |
Sep 06 2017 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 9.75 | 364 | 3,549 | 290,859 | 291.2 K to 290.9 K (-0.12 %) |
Aug 23 2017 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 9.45 | 1,933 | 18,267 | 291,223 | 293.2 K to 291.2 K (-0.66 %) |
Aug 04 2017 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 10.33 | 409 | 4,225 | 293,156 | 293.6 K to 293.2 K (-0.14 %) |
Jun 05 2017 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 12.89 | 357 | 4,602 | 293,565 | 293.9 K to 293.6 K (-0.12 %) |
May 23 2017 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 12.89 | 1,916 | 24,697 | 293,922 | 295.8 K to 293.9 K (-0.65 %) |
May 04 2017 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 13.34 | 394 | 5,256 | 295,838 | 296.2 K to 295.8 K (-0.13 %) |
Mar 09 2017 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 12.18 | 525 | 6,395 | 296,232 | 296.8 K to 296.2 K (-0.18 %) |
Mar 03 2017 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 12.29 | 353 | 4,338 | 296,757 | 297.1 K to 296.8 K (-0.12 %) |
Feb 24 2017 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Feb 24 2017 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Grant | A | 0.00 | 45,000 | 0 | 297,110 | 252.1 K to 297.1 K (+17.85 %) |
Feb 21 2017 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 10.08 | 7,958 | 80,217 | 252,110 | 260.1 K to 252.1 K (-3.06 %) |
Feb 03 2017 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 11.58 | 398 | 4,609 | 260,068 | 260.5 K to 260.1 K (-0.15 %) |
Jan 20 2017 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Option Exercise | M | 0.00 | 8,980 | 0 | 17,959 | |
Jan 20 2017 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Option Exercise | M | 0.00 | 6,289 | 0 | 9,883 | |
Jan 20 2017 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 12.47 | 9,569 | 119,325 | 260,466 | 270 K to 260.5 K (-3.54 %) |
Jan 20 2017 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Buy | M | 0.00 | 17,477 | 0 | 270,035 | 252.6 K to 270 K (+6.92 %) |
Jan 20 2017 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Buy | M | 0.00 | 6,289 | 0 | 252,558 | 246.3 K to 252.6 K (+2.55 %) |
Dec 09 2016 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 11.08 | 527 | 5,839 | 246,269 | 246.8 K to 246.3 K (-0.21 %) |
Dec 06 2016 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 11.30 | 357 | 4,034 | 246,796 | 247.2 K to 246.8 K (-0.14 %) |
Nov 04 2016 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 10.30 | 400 | 4,120 | 245,653 | 246.1 K to 245.7 K (-0.16 %) |
Sep 09 2016 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 8.69 | 523 | 4,545 | 246,053 | 246.6 K to 246.1 K (-0.21 %) |
Sep 06 2016 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 8.62 | 358 | 3,086 | 246,576 | 246.9 K to 246.6 K (-0.14 %) |
Aug 22 2016 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 9.00 | 7,500 | 67,500 | 246,934 | 254.4 K to 246.9 K (-2.95 %) |
Aug 04 2016 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 9.88 | 400 | 3,952 | 254,434 | 254.8 K to 254.4 K (-0.16 %) |
Jun 07 2016 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 8.98 | 524 | 4,706 | 254,834 | 255.4 K to 254.8 K (-0.21 %) |
Jun 07 2016 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 8.53 | 344 | 2,934 | 255,358 | 255.7 K to 255.4 K (-0.13 %) |
May 04 2016 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 5.79 | 396 | 2,293 | 254,202 | 254.6 K to 254.2 K (-0.16 %) |
Mar 09 2016 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 5.76 | 559 | 3,220 | 254,598 | 255.2 K to 254.6 K (-0.22 %) |
Mar 03 2016 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 4.87 | 411 | 2,002 | 255,157 | 255.6 K to 255.2 K (-0.16 %) |
Mar 03 2016 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 4.93 | 1,523 | 7,508 | 255,568 | 257.1 K to 255.6 K (-0.59 %) |
Feb 22 2016 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Option Exercise | A | 0.00 | 26,939 | 0 | 26,939 | |
Feb 22 2016 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Grant | A | 0.00 | 80,738 | 0 | 257,091 | 176.4 K to 257.1 K (+45.78 %) |
Feb 05 2016 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 4.99 | 3,083 | 15,384 | 176,353 | 179.4 K to 176.4 K (-1.72 %) |
Jan 25 2016 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Option Exercise | M | 0.00 | 508 | 0 | 16,172 | |
Jan 25 2016 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 6.80 | 227 | 1,544 | 179,436 | 179.7 K to 179.4 K (-0.13 %) |
Jan 25 2016 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Buy | M | 0.00 | 508 | 0 | 179,663 | 179.2 K to 179.7 K (+0.28 %) |
Dec 10 2015 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 7.26 | 552 | 4,008 | 179,155 | 179.7 K to 179.2 K (-0.31 %) |
Dec 04 2015 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 7.71 | 356 | 2,745 | 179,707 | 180.1 K to 179.7 K (-0.20 %) |
Dec 04 2015 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 7.60 | 1,308 | 9,941 | 180,063 | 181.4 K to 180.1 K (-0.72 %) |
Sep 11 2015 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 9.60 | 536 | 5,146 | 180,040 | 180.6 K to 180 K (-0.30 %) |
Sep 04 2015 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 9.36 | 367 | 3,435 | 180,576 | 180.9 K to 180.6 K (-0.20 %) |
Sep 04 2015 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 9.62 | 1,390 | 13,372 | 180,943 | 182.3 K to 180.9 K (-0.76 %) |
Jun 18 2015 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 9.17 | 537 | 4,924 | 182,333 | 182.9 K to 182.3 K (-0.29 %) |
Jun 05 2015 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 9.83 | 340 | 3,342 | 182,870 | 183.2 K to 182.9 K (-0.19 %) |
Jun 05 2015 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 9.47 | 1,255 | 11,885 | 183,210 | 184.5 K to 183.2 K (-0.68 %) |
Mar 11 2015 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 11.71 | 3,400 | 39,814 | 183,337 | 186.7 K to 183.3 K (-1.82 %) |
Mar 11 2015 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 11.84 | 516 | 6,109 | 186,737 | 187.3 K to 186.7 K (-0.28 %) |
Mar 11 2015 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 12.06 | 6,105 | 73,626 | 187,253 | 193.4 K to 187.3 K (-3.16 %) |
Feb 23 2015 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Option Exercise | A | 0.00 | 16,680 | 0 | 16,680 | |
Feb 23 2015 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Option Exercise | A | 13.17 | 60,600 | 798,102 | 60,600 | |
Feb 23 2015 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Grant | A | 0.00 | 19,182 | 0 | 193,358 | 174.2 K to 193.4 K (+11.01 %) |
Dec 17 2014 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 12.51 | 540 | 6,755 | 174,176 | 174.7 K to 174.2 K (-0.31 %) |
Dec 08 2014 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 12.06 | 1,560 | 18,814 | 174,716 | 176.3 K to 174.7 K (-0.88 %) |
Nov 14 2014 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 11.46 | 52 | 596 | 175,130 | 175.2 K to 175.1 K (-0.03 %) |
Oct 09 2014 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 9.10 | 55 | 501 | 175,182 | 175.2 K to 175.2 K (-0.03 %) |
Sep 16 2014 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 9.86 | 530 | 5,226 | 175,237 | 175.8 K to 175.2 K (-0.30 %) |
Sep 09 2014 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 10.04 | 1,833 | 18,403 | 175,767 | 177.6 K to 175.8 K (-1.03 %) |
Aug 08 2014 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 11.15 | 52 | 580 | 177,600 | 177.7 K to 177.6 K (-0.03 %) |
Jul 15 2014 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 11.89 | 59 | 702 | 177,652 | 177.7 K to 177.7 K (-0.03 %) |
Jun 13 2014 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 11.64 | 491 | 5,715 | 177,711 | 178.2 K to 177.7 K (-0.28 %) |
Jun 05 2014 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 10.78 | 446 | 4,808 | 177,125 | 177.6 K to 177.1 K (-0.25 %) |
Jun 05 2014 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 10.67 | 1,350 | 14,405 | 177,571 | 178.9 K to 177.6 K (-0.75 %) |
May 12 2014 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 9.27 | 50 | 464 | 178,921 | 179 K to 178.9 K (-0.03 %) |
Apr 11 2014 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 9.87 | 56 | 553 | 178,971 | 179 K to 179 K (-0.03 %) |
Mar 13 2014 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Sell | S | 12.17 | 2,050 | 24,940 | 179,027 | 181.1 K to 179 K (-1.13 %) |
Mar 10 2014 | GNMK | GenMark Diagnostic ... | Gleeson Michael | SVP, North American ... | Option Exercise | A | 12.30 | 72,000 | 885,600 | 72,000 |